

					

						November 25, 2017 - By Marguerite Chambers
Senzar Asset Management Llc increased its stake in Alder Biopharmaceuticals Inc (ALDR) by 159.34% based on its latest 2017Q2 regulatory filing with the SEC. Senzar Asset Management Llc bought 342,700 shares as the company’s stock declined 24.25% while stock markets rallied. The hedge fund held 557,770 shares of the health care company at the end of 2017Q2, valued at $6.39M, up from 215,070 at the end of the previous reported quarter. Senzar Asset Management Llc who had been investing in Alder Biopharmaceuticals Inc for a number of months, seems to be bullish on the $710.99 million market cap company. The stock increased 2.44% or $0.25 on November 24, reaching $10.5. About 309,507 shares traded. Alder Biopharmaceuticals Inc (NASDAQ:ALDR) has declined 33.67% since November 25, 2016 and is downtrending. It has underperformed by 50.37% the S&P500.Tocqueville Asset Management Lp increased its stake in Diageo Plc Sponsored Adr (DEO) by 15.45% based on its latest 2017Q2 regulatory filing with the SEC. Tocqueville Asset Management Lp bought 50,176 shares as the company’s stock rose 5.26% with the market. The institutional investor held 374,968 shares of the beverages (production and distribution) company at the end of 2017Q2, valued at $44.93M, up from 324,792 at the end of the previous reported quarter. Tocqueville Asset Management Lp who had been investing in Diageo Plc Sponsored Adr for a number of months, seems to be bullish on the $88.71B market cap company. The stock increased 1.60% or $2.2 on November 24, reaching $139.82. About 291,804 shares traded. Diageo plc (ADR) (NYSE:DEO) has risen 12.82% since November 25, 2016 and is uptrending. It has underperformed by 3.88% the S&P500.Tocqueville Asset Management Lp, which manages about $12.62 billion and $8.34B US Long portfolio, decreased its stake in Lions Gate Entertainment Corp by 26,179 shares to 234,742 shares, valued at $6.17 million in 2017Q2, according to the filing. It also reduced its holding in Intuit Com (NASDAQ:INTU) by 13,732 shares in the quarter, leaving it with 74,628 shares, and cut its stake in Citigroup Cap Xi 7.875 Pfd Du. Among 25 analysts covering Diageo (NYSE:DEO), 16 have Buy rating, 3 Sell and 6 Hold. Therefore 64% are positive. Diageo had 40 analyst reports since July 31, 2015 according to SRatingsIntel. As per Friday, July 31, the company rating was maintained by Deutsche Bank. The firm earned “Hold” rating on Wednesday, September 23 by Shore Capital. JP Morgan maintained the shares of DEO in report on Friday, July 31 with “Neutral” rating. The stock of Diageo plc (ADR) (NYSE:DEO) earned “Overweight” rating by JP Morgan on Friday, November 20. The company was downgraded on Tuesday, January 12 by Stifel Nicolaus. The rating was upgraded by Goldman Sachs to “Neutral” on Tuesday, June 28. Nomura maintained the stock with “Buy” rating in Friday, July 31 report. The stock of Diageo plc (ADR) (NYSE:DEO) earned “Hold” rating by Societe Generale on Monday, June 27. HSBC initiated the shares of DEO in report on Friday, October 16 with “Hold” rating. Credit Suisse upgraded the shares of DEO in report on Thursday, October 29 to “Outperform” rating.Among 16 analysts covering Alder Biopharmaceuticals (NASDAQ:ALDR), 14 have Buy rating, 1 Sell and 1 Hold. Therefore 88% are positive. Alder Biopharmaceuticals had 28 analyst reports since August 6, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Thursday, June 8 by Needham. The firm has “Buy” rating given on Wednesday, September 6 by Mizuho. The firm has “Buy” rating given on Wednesday, July 27 by Jefferies. The firm has “Buy” rating given on Wednesday, April 20 by Brean Capital. RBC Capital Markets maintained Alder Biopharmaceuticals Inc (NASDAQ:ALDR) on Monday, October 16 with “Buy” rating. The stock of Alder Biopharmaceuticals Inc (NASDAQ:ALDR) earned “Buy” rating by Needham on Monday, July 17. As per Thursday, August 24, the company rating was maintained by Credit Suisse. JP Morgan initiated Alder Biopharmaceuticals Inc (NASDAQ:ALDR) rating on Tuesday, September 13. JP Morgan has “Overweight” rating and $40 target. The stock has “Buy” rating by Aegis Capital on Thursday, June 29. As per Wednesday, September 9, the company rating was initiated by Jefferies.More important recent Alder Biopharmaceuticals Inc (NASDAQ:ALDR) news were published by: Globenewswire.com which released: “Alder BioPharmaceuticals® to Present at 29th Annual Piper Jaffray Healthcare …” on November 22, 2017, also Fool.com published article titled: “Why Alder Biopharmaceuticals Inc Is Sinking Today”, Globenewswire.com published: “Alder BioPharmaceuticals® to Present at 26th Annual Credit Suisse Healthcare …” on November 01, 2017. More interesting news about Alder Biopharmaceuticals Inc (NASDAQ:ALDR) was released by: Globenewswire.com and their article: “Alder BioPharmaceuticals® Announces Third Quarter 2017 Financial and Operating …” with publication date: November 07, 2017.Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.



(adsbygoogle = window.adsbygoogle || []).push({});
TRADE IDEAS REVIEW – IS THIS THE BEST STOCK SCANNER?

Trade Ideas is arguably one of the top scanning tools available on the market right

Trade Ideas Pro helps traders find the best setups in the market right NOW

Scottrade and E*TRADE license Trade Ideas proprietary technology for their premium trading platforms. We have fully automated trading available through Lightspeed and Interactive Brokers.Trade Ideas is the BEST Tool for Scanning. I would be LOST without Trade ideas. Ross Cameron – Warrior Trading